Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Feldman

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Human Vaccines & Immunotherapeutics|November 21, 2015
Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancerRebecca Luckett, Sarah Feldman
Current Treatment Options in Oncology|October 16, 2015
Making Sense of Cervical Cancer Screening Guidelines and RecommendationsMichelle Davis, Sarah Feldman
JAMA Internal Medicine|November 21, 2022
Cervical Cancer Prevention and Cost for Women Older Than 65 Years in the US-Are We Spending Too Much or Too Little?Sarah Feldman, Stephanie Alimena
Hematology/Oncology Clinics of North America|January 17, 2012
Management of cervical precancers: a global perspectiveDaniel Echelman, Sarah Feldman
Clinical Obstetrics and Gynecology|January 16, 2013
Cost-effectiveness of cervical cancer preventionKatharine M Esselen, Sarah Feldman
JAMA Network Open|March 12, 2025
Why Are US Cervical Cancer Screening Exit Criteria Failing?Rebecca B Perkins, Sarah Feldman
Current Problems in Cancer|August 28, 2018
Update on primary HPV screening for cervical cancer preventionAnthony E Rizzo, Sarah Feldman
Journal of the National Cancer Institute|July 2, 2020
How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer PreventionSarah Feldman, Jennifer S Haas
Birth (Berkeley, Calif.)|March 19, 2016
Survey of Obstetric Care and Cesarean Delivery Rates in Shanghai, ChinaSusan Hellerstein, Sarah Feldman, Tao Duan
Journal of Lower Genital Tract Disease|March 24, 2018
The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity?Phil Castle, Sarah Feldman, Rebecca B Perkins
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Human Vaccines & Immunotherapeutics|November 21, 2015
Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancerRebecca Luckett, Sarah Feldman
Current Treatment Options in Oncology|October 16, 2015
Making Sense of Cervical Cancer Screening Guidelines and RecommendationsMichelle Davis, Sarah Feldman
JAMA Internal Medicine|November 21, 2022
Cervical Cancer Prevention and Cost for Women Older Than 65 Years in the US-Are We Spending Too Much or Too Little?Sarah Feldman, Stephanie Alimena
Hematology/Oncology Clinics of North America|January 17, 2012
Management of cervical precancers: a global perspectiveDaniel Echelman, Sarah Feldman
Clinical Obstetrics and Gynecology|January 16, 2013
Cost-effectiveness of cervical cancer preventionKatharine M Esselen, Sarah Feldman
JAMA Network Open|March 12, 2025
Why Are US Cervical Cancer Screening Exit Criteria Failing?Rebecca B Perkins, Sarah Feldman
Current Problems in Cancer|August 28, 2018
Update on primary HPV screening for cervical cancer preventionAnthony E Rizzo, Sarah Feldman
Journal of the National Cancer Institute|July 2, 2020
How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer PreventionSarah Feldman, Jennifer S Haas
Birth (Berkeley, Calif.)|March 19, 2016
Survey of Obstetric Care and Cesarean Delivery Rates in Shanghai, ChinaSusan Hellerstein, Sarah Feldman, Tao Duan
Journal of Lower Genital Tract Disease|March 24, 2018
The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity?Phil Castle, Sarah Feldman, Rebecca B Perkins
Pageof 11